EQUILLIUM INC (EQ) Stock News

On Friday, there are stocks with unusual volume. Let's take a look.

Discover the stocks with unexpected trading volume in today's session on the US markets.

Mentions: ZDGE VXRT HSDT IPA ...

Unusual volume stocks are being observed in Thursday's session.

Unusual volume stocks are being observed in Thursday's session.

Mentions: AIHS RFL HSDT DPRO ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

Mentions: CAMP SLP SCLX HCTI ...

Stay updated with the stocks that are on the move in today's after-hours session.

Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.

Mentions: DAN OXM GTI GME ...

Equillium Announces Multiple Poster Presentations Highlighting EQ504 at the Annual Meeting of The American Association of Immunologists

Equillium Announces New Aryl Hydrocarbon Receptor Modulator Program EQ504

Equillium Announces Feedback from the U.S. Food and Drug Administration

Nasdaq Down Over 100 Points; US Initial Jobless Claims Fall

Mentions: GTEC AUUD NXU DRMA ...

Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease

Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights

Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis

Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates

Equillium to Present at the Stifel Healthcare Conference

Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer

Equillium Maintains Rights to Itolizumab Following Ono Partnership

Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer

Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference

EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q2 2024

EQ stock results show that Equillium beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Equillium (NASDAQ:EQ) just reported results for the second quarter of 2024.Equi...

Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights

Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease

Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance

Equillium to Participate in Upcoming Investor Conferences

Equillium to be included in the Russell Microcap® Index